S Houlbrook

1.2k total citations
17 papers, 1.0k citations indexed

About

S Houlbrook is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, S Houlbrook has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in S Houlbrook's work include Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (4 papers) and DNA Repair Mechanisms (2 papers). S Houlbrook is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (4 papers) and DNA Repair Mechanisms (2 papers). S Houlbrook collaborates with scholars based in United Kingdom, India and Greece. S Houlbrook's co-authors include Adrian L. Harris, J Carmichael, Ian D. Hickson, Ian J. Stratford, Christine Blancher, Kate Talks, John W. Moore, Grigory L. Dianov, Michael J. Greenall and Denis Talbot and has published in prestigious journals such as Nucleic Acids Research, British Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

S Houlbrook

16 papers receiving 990 citations

Peers

S Houlbrook

ONCOL

TOXIC

GENET

Diane E. Brattain United States

Hisato Gunji United States

Hitoshi Arioka Japan

Victoria J. Spanswick United Kingdom

Ayako Yukita Japan

Faina Vikhanskaya Italy

Mollie H. Wright United States

Akiko Tohgo Japan

Murray J. Towle United States

Takashi Kobunai Japan

Diane E. Brattain United States

S Houlbrook

731 ×1.0

492 ×1.2

ONCOL

229 ×0.9

39 ×0.4

TOXIC

106 ×1.2

GENET

Citations per year, relative to S Houlbrook S Houlbrook (= 1×) peers Diane E. Brattain

Countries citing papers authored by S Houlbrook

Since Specialization

Citations

This map shows the geographic impact of S Houlbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Houlbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Houlbrook more than expected).

Fields of papers citing papers by S Houlbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Houlbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Houlbrook. The network helps show where S Houlbrook may publish in the future.

Co-authorship network of co-authors of S Houlbrook

This figure shows the co-authorship network connecting the top 25 collaborators of S Houlbrook. A scholar is included among the top collaborators of S Houlbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Houlbrook. S Houlbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Chan, Kannie W. Y., S Houlbrook, Q.-M. Zhang, et al.. (2007). Overexpression of DNA polymerase results in an increased rate of frameshift mutations during base excision repair. Mutagenesis. 22(3). 183–188. 38 indexed citations

Madhusudan, Srinivasan, Frank W. Smart, Jason L. Parsons, et al.. (2005). Isolation of a small molecule inhibitor of DNA base excision repair. Nucleic Acids Research. 33(15). 4711–4724. 197 indexed citations

Blancher, Christine, John W. Moore, Kate Talks, S Houlbrook, & Adrian L. Harris. (2000). Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.. PubMed. 60(24). 7106–13. 187 indexed citations

Braybrooke, Jeremy, David Propper, Kenneth J. O’Byrne, et al.. (2000). Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha. British Journal of Cancer. 83(2). 219–224. 13 indexed citations

Braybrooke, Jeremy, S Houlbrook, David Propper, et al.. (2000). Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen. Cancer Chemotherapy and Pharmacology. 45(2). 111–119. 18 indexed citations

Chao, David, et al.. (1999). Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay. British Journal of Cancer. 81(8). 1280–1284. 25 indexed citations

Turley, Helen, M Comley, S Houlbrook, et al.. (1997). The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. British Journal of Cancer. 75(9). 1340–1346. 145 indexed citations

Houlbrook, S, Adrian L. Harris, J Carmichael, & Ian J. Stratford. (1996). Relationship between topoisomerase II levels and resistance to topoisomerase II inhibitors in lung cancer cell lines.. PubMed. 16(4A). 1603–10. 13 indexed citations

Houlbrook, S, et al.. (1995). Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines. British Journal of Cancer. 72(6). 1454–1461. 53 indexed citations

10.

Houlbrook, S, et al.. (1993). Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.. PubMed. 8(4). 933–8. 103 indexed citations

11.

Kirk, J, S Houlbrook, N Stuart, et al.. (1993). Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites. British Journal of Cancer. 67(6). 1189–1195. 39 indexed citations

12.

Kirk, J, S Houlbrook, N Stuart, et al.. (1993). Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites. European Journal of Cancer. 29(8). 1152–1157. 30 indexed citations

13.

Philip, P. A., Adrian L. Harris, Katia Tonkin, et al.. (1992). High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines. British Journal of Cancer. 66(5). 833–839. 54 indexed citations

14.

Robertson, Naomi, Ian J. Stratford, S Houlbrook, J Carmichael, & G.E. Adams. (1992). The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?. Biochemical Pharmacology. 44(3). 409–412. 72 indexed citations

15.

Layer, G T, K G Burnand, Patrick J. Gaffney, et al.. (1987). Tissue plasminogen activators in breast cancer. Thrombosis Research. 45(5). 601–607. 18 indexed citations

16.

Layer, G T, S.A. Cederholm-Williams, Patrick J. Gaffney, et al.. (1987). Urokinase—the enzyme responsible for invasion and metastasis in human breast carcinoma?. Fibrinolysis and Proteolysis. 1(4). 237–240. 11 indexed citations

17.

Layer, G T, S.A. Cederholm-Williams, P.J. Gaffney, et al.. (1985). Characterisation of the fibrinolytic enzymes associated with malignant invasion in carcinoma of the breast. Regulatory Peptides. 13(1). 80–80.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact